I Guess I Wasn’t “Sick Enough”

The first time my insurance denied coverage for a GLP-1 medication, the message was clear: I wasn’t sick enough.

It apparently didn't matter that I had lived with obesity for the majority of my life. Never mind the countless diets, the calorie-counting apps, the lifestyle changes, or the hours spent learning about nutrition and inflammation. Never mind that I had already been diagnosed with nonalcoholic fatty liver disease (NAFLD), a metabolic condition closely linked to obesity.

Simply because I wasn’t diabetic or prediabetic, my insurance company decided I didn’t qualify for treatment. More on that later. Insert sigh. It’s a frustrating reality many people living with obesity face. Even though obesity is recognized as a chronic disease by major medical organizations, much of our healthcare system still treats it like an optional lifestyle issue. That mindset can make accessing evidence-based treatment far more difficult than it should be. It can also be incredibly exhausting.

Why metabolic health is about more than just weight

When I began exploring GLP-1 medications, it wasn’t because I hadn’t tried other approaches. Like many people living with obesity, I had spent years doing everything that conventional advice recommends. However, my body continued to struggle metabolically. My body fought me every step of every journey I attempted.

When my NAFLD diagnosis and higher cholesterol entered the picture, it became clear that this wasn’t just about weight. It was now about long-term health risks. Yet, insurance guidelines often prioritize treatment only after complications like type 2 diabetes appear. In other words, many patients are expected to get sicker before qualifying for help. And in my opinion, that approach feels incredibly backward when early intervention can potentially prevent serious complications.

Understanding the prior authorization and appeals process

The denial was discouraging, but it also introduced me to a process many patients don’t realize exists: the appeals process. Most medications like GLP-1s require prior authorization (PA). This means your healthcare provider must submit documentation proving the medical necessity of the treatment.

Submitting everything proving that this type of medical intervention would benefit me and still getting a second denial was a feeling of utter defeat. I had to remind myself that advocating for my health wasn’t being difficult, it was being proactive, and I was far from done.

The power of a multi-disciplinary care team

One thing that made a significant difference in navigating this process was having multiple providers who understood the medical complexity of obesity and metabolic health. Each of my doctors played a role in building the case for medical weight management:

• General Practitioner: Helped initiate the prior authorization and document my long history of obesity and attempts at lifestyle changes.
• Gastroenterologist: Added critical context because of my NAFLD diagnosis. Fatty liver disease is increasingly recognized as part of the broader metabolic dysfunction associated with obesity, and treatments that improve metabolic health can benefit liver health as well.
• Cardiologist: Contributed another important perspective by documenting cardiovascular risk factors associated with obesity. Addressing those risks early is an important form of preventative care.

Together, their documentation helped paint a clearer picture: this wasn’t cosmetic weight loss. It was treatment for a complex medical condition.

Turning to telehealth when traditional insurance fails

One of the most surprising parts of navigating this experience was realizing how much patients are expected to advocate for themselves. Living with obesity already comes with social stigma and, at times, medical bias. Adding administrative barriers like insurance denials denials can feel overwhelming.

But I discovered that persistence matters. Since I couldn’t get GLP-1 through traditional insurance, telehealth was my next route. Once I found a company that checked all of my boxes, I never looked back. For me, this journey wasn’t just about weight. My NAFLD diagnosis was a wake-up call that my metabolic health needed attention before more serious complications developed.

Taking control of your health advocacy

The lifestyle changes I made helped improve my labs and my understanding of my body, but they also showed me how complex metabolic health really is. Sometimes lifestyle alone isn’t enough, and pharmacological treatment can be an important tool.

If sharing my experience helps even one person feel empowered to push back after an insurance denial or ask their provider about treatment options, it’s worth it. And if you continue to hit a roadblock like me, know that there are other resources that can help fill in those gaps! Because no one should have to wait until their health gets worse before they’re taken seriously.